Sex differences in corticotropin-releasing factor receptor signaling and trafficking: Potential role in female vulnerability to stress-related psychopathology

Molecular Psychiatry

Volumn 15, Issue 9, 2010, Pages 896-904

  Bangasser, D A ^a   Curtis, A ^a   Reyes, B A S ^b   Bethea, T T ^a   Parastatidis, I ^a   Ischiropoulos, H ^a   Van Bockstaele, E J ^b   Valentino, R J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

corticotropin releasing hormone; depression; locus ceruleus; norepinephrine; post traumatic stress disorder; stress

Indexed keywords

BETA ARRESTIN 2; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; NORADRENALIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; IMMUNOELECTRON MICROSCOPY; INTERNALIZATION; LOCUS CERULEUS; MALE; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

EID: 77956448518     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.66     Document Type: Article

References (64)

1. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29: 85-96.
2. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
3. Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J et al. Gender differences in depression: findings from the STAR*D study. J Affect Disord 2005; 87: 141-150.
4. Ter Horst GJ, Wichmann R, Gerrits M, Westenbroek C, Lin Y. Sex differences in stress responses: focus on ovarian hormones. Physiol Behav 2009; 97: 239-249.
5. Young EA, Altemus M. Puberty, ovarian steroids, and stress. Ann NY Acad Sci 2004; 1021: 124-133.
6. Young EA. Sex differences in response to exogenous corticoster-one: a rat model of hypercortisolemia. Mol Psychiatry 1996; 1: 313-319.
7. Young EA, Ribeiro SC, Ye W. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology 2007; 32: 503-507.
8. Gold PW, Wong ML, Chrousos GP, Licinio J. Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications. Mol Psychiatry 1996; 1: 257-264.
9. Smith MA, Kling MA, Whitfield HJ, Brandt HA, Demitrack MA, Geracioti TD et al. Corticotropin-releasing hormone: from endocrinology to psychobiology. Horm Res 1989; 31: 66-71.
10. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002; 7: 254-275.
11. Strohle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003; 36(Suppl 3): S207-S214.
12. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92: 1896-1902.
13. Vamvakopoulos NV. Sexual dimorphism of stress response and immune/inflammatory reaction: the corticotropin releasing hormone perspective. Mediators Inflamm 1995; 4: 163-174.
14. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of cortico-tropin and beta-endorphin. Science 1981; 213: 1394-1397.
15. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525-557.
16. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 1991; 43: 425-473.
17. Van Bockstaele EJ, Colago EE, Valentino RJ. Corticotropin-releas-ing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 1996; 364: 523-534.
18. Van Bockstaele EJ, Colago EE, Valentino RJ. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the coordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 1998; 10: 743-757.
19. Valentino RJ, Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008; 583: 194-203.
20. Aston-Jones G, Rajkowski J, Kubiak P, Valentino RJ, Shipley MT. Role of the locus coeruleus in emotional activation. Prog Brain Res 1996; 107: 380-402.
21. Page ME, Berridge CW, Foote SL, Valentino RJ. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci Lett 1993; 164: 81-84.
22. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997; 756: 114-124.
23. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000; 97: 325-330
24. ODonnell T, Hegadoren KM, Coupland NC. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology 2004; 50: 273-283.
25. Southwick SM, Bremner JD, Rasmusson A, Morgan III CA, Arnsten A, Charney DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 46: 1192-1204.
26. Curtis AL, Bethea T, Valentino RJ. Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 2006; 31: 544-554.
27. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotro-pin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006; 27: 260-286.
28. Teli T, Markovic D, Levine MA, Hillhouse EW, Grammatopoulos DK. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization. Mol Endocrinol 2005; 19: 474-490.
29. Oakley RH, Olivares-Reyes JA, Hudson CC, Flores-Vega F, Dautzenberg FM, Hauger RL. Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses. Am J Physiol Regul Integr Comp Physiol 2007; 293: R209-R222.
30. Carr GV, Bangasser DA, Bethea T, Young M, Valentino RJ, Lucki I. Antidepressant-Like Effects of kappa-Opioid Receptor Antagonists in Wistar Kyoto Rats. Neuropsychopharmacology 2009; 35: 752-763.
31. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci 2006; 23: 2991-2998.
32. Reyes BA, Valentino RJ, Van Bockstaele EJ. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 2008; 149: 122-130.
33. Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL, Zaczek R. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies. J Pharmacol Exp Ther 1998; 286: 459-468.
34. Chen FM, Bilezikjian LM, Perrin MH, Rivier J, Vale W. Cortico-tropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res 1986; 381: 49-57.
35. Battaglia G, Webster EL, De Souza EB. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse 1987; 1: 572-581.
36. De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995; 20: 789-819.
37. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
38. Premont RT. Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity. Neuromolecular Med 2005; 7: 129-147.
39. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998; 38: 289-319.
40. Holmes KD, Babwah AV, Dale LB, Poulter MO, Ferguson SS. Differential regulation of corticotropin releasing factor 1alpha receptor endocytosis and trafficking by beta-arrestins and Rab GTPases. J Neurochem 2006; 96: 934-949.
41. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005; 4: 141-194.
42. Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuro-peptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand 1991; 83: 273-277.
43. Viau V, Bingham B, Davis J, Lee P, Wong M. Gender and puberty interact on the stress-induced activation of parvocellular neuro-secretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 2005; 146: 137-146.
44. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, Shibasaki T. Gender differences in corticotropin and corticoster-one secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 2009; 34: 226-237.
45. Desbonnet L, Garrett L, Daly E, McDermott KW, Dinan TG. Sexually dimorphic effects of maternal separation stress on corticotrophin-releasing factor and vasopressin systems in the adult rat brain. Int J Dev Neurosci 2008; 26: 259-268.
46. Patchev VK, Hayashi S, Orikasa C, Almeida OF. Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment. Stress 1999; 3: 41-54.
47. Seale JV, Wood SA, Atkinson HC, Harbuz MS, Lightman SL. Postnatal masculinization alters the HPA axis phenotype in the adult female rat. J Physiol 2005; 563(Part 1): 265-274.
48. Van De Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C et al. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta. Mol Endocrinol 2004; 18: 2908-2923.
49. Bohler Jr HC, Zoeller RT, King JC, Rubin BS, Weber R, Merriam GR. Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat. Brain Res Mol Brain Res 1990; 8: 259-262.
50. Speert DB, SJ MC, Seasholtz AF. Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology 2002; 143: 4730-4741.
51. Jedema HP, Grace AA. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 2004; 24: 9703-9713.
52. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994; 91: 8777-8781.
53. Grammatopoulos DK, Randeva HS, Levine MA, Kanellopoulou KA, Hillhouse EW. Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J Neurochem 2001; 76: 509-519.
54. Refojo D, Echenique C, Muller MB, Reul JM, Deussing JM, Wurst W et al. Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci USA 2005; 102: 6183-6188.
55. Curtis AL, Pavcovich LA, Grigoriadis DE, Valentino RJ. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience 1995; 65: 541-550.
56. Valentino RJ, Van Bockstaele EJ. Functional interactions between stress neuromediator and the locus coeruleur-noradrenaline system. In: Steckler TK, N. (ed). Handbook of Stress and the Brain. Elsevier: The Netherlands, 2005 pp 465-486.
57. Curtis AL, Pavcovich LA, Valentino RJ. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress. J Pharmacol Exp Ther 1999; 289: 1211-1219.
58. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z. Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol 2009; 106: 226-233.
59. Palanza P. Animal models of anxiety and depression: how are females different? Neurosci Biobehav Rev 2001; 25: 219-233.
60. Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004; 9: 326-357.
61. Aston-Jones G, Rajkowski J, Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res 2000; 126: 165-182.
62. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 2005; 28: 403-450. (Pubitemid 41098911)
63. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003; 42: 33-84.
64. Nemeroff CB. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996; 1: 336-342.